CA Patent

CA2536902A1 — Proton pump inhibitor formulations, and methods of preparing and using such formulations

Assigned to AGI Therapeutics Ltd · Expires 2005-03-10 · 21y expired

What this patent protects

Pharmaceutical formulation comprising at least one proton pump inhibitor structured and arranged to provide an initial pH independent time-based delayed-release, and a subsequent extended-release of the at least one proton pump inhibitor.

USPTO Abstract

Pharmaceutical formulation comprising at least one proton pump inhibitor structured and arranged to provide an initial pH independent time-based delayed-release, and a subsequent extended-release of the at least one proton pump inhibitor.

Drugs covered by this patent

Patent Metadata

Patent number
CA2536902A1
Jurisdiction
CA
Classification
—
Expires
2005-03-10
Drug substance claim
No
Drug product claim
No
Assignee
AGI Therapeutics Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.